YAP coordinates lipid and cholesterol metabolism in papillary thyroid cancer through a glucose–AMPK-gated TEAD1–SREBP1/2 axis
Endocrine-Related Cancer · 04.11.2026
DOI: 10.1530/erc-26-0269 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine-Related Cancer, online erschienen am 04.11.2026. Verfasst von Hong Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine , Shanghai, China. Hauptthemen laut MEDLINE: Transcription Factors, Thyroid Neoplasms, Thyroid Cancer, Papillary, DNA-Binding Proteins.
Abstract (Originalsprache)
To determine whether Yes-associated protein (YAP), a transcriptional coactivator frequently activated in cancer, coordinates lipid and cholesterol metabolism in papillary thyroid cancer (PTC), YAP was overexpressed or silenced in BCPAP and TPC-1 cells, and transcriptomic, biochemical and functional analyses were performed. Glucose deprivation and the AMP-activated protein kinase (AMPK) activator metformin suppressed YAP nuclear localization and lipogenic programs, whereas AMPK inhibition by Compound C or YAP overexpression (OE) restored them. Mechanistically, YAP associated with TEA domain family member 1 (TEAD1), occupied canonical TEAD-binding motifs in the SREBF1 and SREBF2 promoters, and activated their transcription in a TEAD1-dependent manner: TEAD1 knockdown abolished YAP-induced SREBF promoter activity, while eight-group genetic epistasis experiments showed that TEAD1 or SREBP1/2 depletion was required for YAP-driven proliferation, clonogenic growth, neutral-lipid and cholesterol accumulation, and expression of FASN, SCD, HMGCR and HMGCS1. Pharmacological SREBP blockade by fatostatin or AMPK activation by metformin reversed YAP-driven phenotypes in vitro and restrained xenograft growth in vivo, with comparable tumor-weight inhibition between the two treatments and no effect on body weight.Clinically, YAP1 expression correlated with lipogenic genes and with shorter disease-free survival in the TCGA-THCA cohort and with SREBP expression in 200 paired PTC specimens. These findings support a model in which glucose–AMPK signaling gates a YAP–TEAD1–SREBP1/2 axis that promotes lipid and cholesterol metabolism and PTC growth, and suggest metformin and SREBP-targeting strategies as candidate therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine , Shanghai, China.
ORCID-Profile: Zhongling Qiu, Quanyong Luo, Chentian Shen
Zitieren
APA
Chen, H., Wang, J., Zhu, Y., Song, H., Qiu, Z., Luo, Q., & Shen, C. (2026). YAP coordinates lipid and cholesterol metabolism in papillary thyroid cancer through a glucose–AMPK-gated TEAD1–SREBP1/2 axis. Endocrine-Related Cancer. https://doi.org/10.1530/erc-26-0269
Vancouver
Chen H, Wang J, Zhu Y, Song H, Qiu Z, Luo Q, et al. YAP coordinates lipid and cholesterol metabolism in papillary thyroid cancer through a glucose–AMPK-gated TEAD1–SREBP1/2 axis. Endocrine-Related Cancer. 2026. doi:10.1530/erc-26-0269
BibTeX
@article{Chen2026,
author = {Chen, Hong and Wang, Jiangfeng and Zhu, Yunyun and Song, Hongjun and Qiu, Zhongling and Luo, Quanyong and Shen, Chentian},
title = {YAP coordinates lipid and cholesterol metabolism in papillary thyroid cancer through a glucose–AMPK-gated TEAD1–SREBP1/2 axis},
journal = {Endocrine-Related Cancer},
year = {2026},
doi = {10.1530/erc-26-0269}
}
EUVIMED